WHX LABS DUBAI 2026 Successfully Concluded | Microprofit Strengthens Global IVD Partnerships

Dubai, UAE – February 2026

WHX Labs Dubai 2026 (formerly Medlab Middle East) has successfully concluded at the Dubai World Trade Centre. As a professional in vitro diagnostics (IVD) manufacturer specializing in diagnostic devices, diagnostic reagents, and POCT systems, Microprofit Biotech sincerely thanks all new and long-standing clients, global distributors, medical device agents, and healthcare partners who visited our booth for in-depth discussions and technical exchanges.

Throughout the exhibition, Microprofit engaged with international IVD distributors, diagnostic reagent suppliers, medical equipment importers, laboratory solution providers, and OEM/ODM partners from multiple regions. The event provided valuable opportunities to strengthen cooperation in the fields of in vitro diagnostics, rapid diagnostic tests, fluorescence immunoassay systems, and point-of-care testing (POCT).

Supporting Global IVD Device & Reagent Distribution Networks

As an experienced IVD device and diagnostic reagent manufacturer, Microprofit remains committed to supporting:

• National and regional IVD distributors and agents

• Medical device and diagnostic reagent importers

• Healthcare procurement organizations

• Laboratory and hospital supply chains

• OEM/ODM diagnostic brand collaborations

Our participation in WHX Labs Dubai 2026 further strengthened cooperation with partners seeking reliable supply of:

• Rapid diagnostic test kits

• Quantitative POCT platforms

• Fluorescence immunoassay analyzers

• Diagnostic reagents and consumables

• Clinical laboratory testing systems

Product Highlights: Rapid Diagnostic Tests & FIA Quantitative POCT Platform

During the exhibition, Microprofit presented a comprehensive portfolio covering both IVD instruments and diagnostic reagents, including:

• FIA quantitative POCT platform

• Fluorescence immunoassay (FIA) analyzers

• Infectious disease rapid test kits

• Immunoassay detection reagents

• Biomarker testing solutions

• Portable point-of-care diagnostic devices

• Clinical laboratory equipment and consumables

Our FIA quantitative POCT system, designed for accurate and fast quantitative detection, received strong interest from global distributors seeking scalable diagnostic solutions suitable for hospitals, clinics, laboratories, and decentralized healthcare environments.

The integration of diagnostic devices and matched reagent systems enables stable performance, consistent quality, and efficient workflow for healthcare providers.

fluorecare® – The Diagnostic Brand of Microprofit Biotech

fluorecare® is the proprietary diagnostic brand of Microprofit Biotech, representing our portfolio of rapid diagnostic tests, fluorescence immunoassay (FIA) systems, quantitative POCT platforms, and matched IVD reagents.

Under the fluorecare® brand, Microprofit provides:

• Rapid testing solutions for infectious diseases

• Quantitative POCT diagnostic systems

• Immunoassay reagent kits

• Integrated IVD device-and-reagent solutions

• Scalable product lines for global medical distributors

fluorecare® supports international IVD distributors, medical device agents, diagnostic reagent wholesalers, and healthcare solution providers seeking stable supply, technical support, and long-term cooperation.

Continuing Global Cooperation in IVD & POCT

WHX Labs Dubai 2026 provided an important platform for meaningful engagement with partners in the fields of:

• In vitro diagnostic devices

• Diagnostic reagents and consumables

• Rapid test kit manufacturing

• POCT diagnostic systems

• Medical laboratory equipment distribution

We sincerely appreciate the trust and valuable discussions shared during the exhibition. Microprofit remains committed to developing reliable, compliant, and practical diagnostic solutions to support healthcare providers worldwide.

For distribution inquiries, OEM/ODM cooperation, or product information regarding IVD devices, diagnostic reagents, POCT systems, rapid test kits, and fluorecare® products, please contact our international business team.

We look forward to continued collaboration and meeting our global partners again at future international medical exhibitions.